Abstract
Y. Jessica Huang, Alexis Harrison, Vikren Sarkar, Prema Rassiah-Szegedi, Martin Szegedi, Brent Wilson, David K. Gaffney, Bill J. Salter
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy
10.1200/jco.1994.12.3.447 · 1994
Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ- at-risk segmentation and dose tolerances in left-sided tangential breast radiation
10.1016/j.prro.2012.06.007 · 2013
Fraction size and dose parameters related to the incidence of pericardial effusions
10.1016/s0360-3016(97)00584-1 · 1998
The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers
10.1053/clon.2003.0218 · 2003
Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy
10.1016/j.ijrobp.2007.10.056 · 2008
Coronary artery disease mortality in patients treated for Hodgkin's disease
10.1002/cncr.2820690528 · 1992
Cardiac disease following treatment of Hodgkin's disease in children and adolescents
10.1200/jco.1993.11.7.1208 · 1993
Factors affecting late mortality from heart disease after treatment of Hodgkin's disease
10.1001/jama.1993.03510160067031 · 1993
Late cardiotoxicity after treatment for Hodgkin lymphoma
10.1182/blood-2006-07-034405 · 2007
Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study
10.1093/jnci/djk029 · 2007
Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors
10.1016/j.ijrobp.2013.05.049 · 2013
Cardiovascular complications of radiotherapy
10.1016/j.amjcard.2013.07.031 · 2013
Radiation dose-volume effects in the heart
10.1016/j.ijrobp.2009.04.093 · 2010
Long-term cardiac mortality after radiotherapy of breast cancer—Application of the relative seriality model
10.1259/0007-1285-69-825-839 · 1996
Predicting radiotherapy-induced cardiac perfusion defects
10.1118/1.1823571 · 2005
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: A report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
10.1093/ehjci/jet123 · 2013
Assessment of myocardial fibrosis with cardiovascular magnetic resonance
10.1016/j.jacc.2010.11.013 · 2011
Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease
10.1161/circulationaha.105.570648 · 2006
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
10.1016/j.jacc.2006.07.049 · 2006
Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy
10.1016/j.jacc.2008.03.018 · 2008
Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis
10.1016/j.jcmg.2009.08.008 · 2009
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy
10.1016/j.jacc.2010.05.010 · 2010
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
10.1186/1532-429x-10-5 · 2008
New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation
10.1016/j.jacc.2008.05.062 · 2008
Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation
10.1161/circulationaha.108.811877 · 2009
Multimodality image registration by maximization of mutual information
10.1109/42.563664 · 1997
Multi-modal volume registration by maximization of mutual information
10.1016/s1361-8415(01)80004-9 · 1996
Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model
10.1016/s0167-8140(00)00166-3 · 2000
Risk of ischemic heart disease in women after radiotherapy for breast cancer
10.1056/nejmoa1209825 · 2013
Complication probability as assessed from dose-volume histograms
10.2307/3583506 · 1985
Fitting of normal tissue tolerance data to an analytic function
10.1016/0360-3016(91)90172-z · 1991
Use of normal tissue complication probability models in the clinic
10.1016/j.ijrobp.2009.07.1754 · 2010
CERR: A computational environment for radiotherapy research
10.1118/1.1568978 · 2003
Dose response in human and experimental radiation-induced heart disease. Application of the nominal standard dose (NSD) concept
10.1148/99.2.403 · 1971
Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications
10.1002/1097-0142(197606)37:6<2813::aid-cncr2820370637>3.0.co;2-s · 1976
Pericarditis and myocardial infarctions after Hodgkin's disease therapy
10.1016/0360-3016(91)90794-5 · 1991
Radiation injury to the heart
10.1016/0360-3016(94)00656-6 · 1995
Radiation-associated cardiovascular disease
10.1016/s1040-8428(01)00227-x · 2003
Cardiac complications of thoracic irradiation
10.1016/j.jacc.2013.01.090 · 2013
Cardiovascular complications of radiation therapy for thoracic malignancies: The role for non-invasive imaging for detection of cardiovascular disease
10.1093/eurheartj/eht114 · 2014
Automatic classification of scar tissue in late enhancement cardiac MRI for the assessment of left-atrial wall injury after radio frequency ablation
10.1117/12.910833 · doi-reference
Dosimetric effects of jaw tracking in step-and-shoot intensity-modulated radiation therapy
10.1120/jacmp.v13i2.3707 · doi-reference
A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: Reduction in normal tissue dose and second cancer risk
10.1186/1748-717x-2-13 · doi-reference
Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapy
10.1093/annonc/mdr439 · doi-reference
3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: Doses to cardiac structures
10.1186/1748-717x-1-10 · doi-reference